TOI

The Oncology Institute, Inc. Common Stock

4.19

USD

TOI Earnings Reports

Positive Surprise Ratio

TOI beat 0 of 10 last estimates.

Next Report

Date of Next Report

Mar 23, 2026

Estimate for Q4 25 (Revenue/ EPS)

$141.17M

-$0.09

Implied change from Q3 25 (Revenue/ EPS)

+3.37%

-35.71%

Implied change from Q4 24 (Revenue/ EPS)

The Oncology Institute, Inc. Common Stock earnings per share and revenue

On Nov 13, 2025, TOI reported earnings of -0.14 USD per share (EPS) for Q3 25, missing the estimate of -0.11 USD, resulting in a -22.27% surprise. Revenue reached 136.56 million, compared to an expected 123.86 million, with a 10.26% difference. The market reacted with a +28.90% price change (close before vs. close after earnings).

Looking ahead to Q4 25, 5 analysts forecast an EPS of -0.09 USD, with revenue projected to reach 141.17 million USD, implying an decrease of -35.71% EPS, and increase of 3.37% in Revenue from the last quarter.

FAQ

What were The Oncology Institute, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?

For Q3 2025, The Oncology Institute, Inc. Common Stock reported EPS of -$0.14, missing estimates by -22.27%, and revenue of $136.56M, 10.26% above expectations.

How did the market react to The Oncology Institute, Inc. Common Stock's Q3 2025 earnings?

The stock price moved up 28.9%, changed from $3.08 before the earnings release to $3.97 the day after.

When is The Oncology Institute, Inc. Common Stock expected to report next?

The next earning report is scheduled for Mar 23, 2026.

What are the forecasts for The Oncology Institute, Inc. Common Stock's next earnings report?

Based on 5 analysts, The Oncology Institute, Inc. Common Stock is expected to report EPS of -$0.09 and revenue of $141.17M for Q4 2025.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.